The device was returned to w.L.Gore & associates for investigation.Submitted in formalin were two gore-tex® vascular graft device fragments (vgf-1 & vgf-2) which had been transected prior to arrival at w.L.Gore and associates.Both fragments were light tan, largely devoid of tissue, had multiple areas of serration marks present on the abluminal surfaces, and the lumens were widely patent.Vgf-1 had no rings present and was cut in a beveled pattern and also longitudinally, consistent with site of anastomosis.Beveled and longitudinal cut edges were lined with holes and a full thickness tear was present.Multiple fragments of blue suture were present, looped through the material, along the beveled edge.Vgf-1 had also been transected at the opposite end with radial film disruption present; this pole appeared to align with vgf-2.Vgf-2 had been transected at both poles.One end had an area of irregular edge, consistent with the heel of the anastomosis, with multiple full thickness tears.Three rings remained intact and firmly adhered at the opposite end, eight removed ring sights were visible.Backlighting/ luminal lighting of the graft revealed no holes in the body of the graft or adjacent to the rings.Histopathological examination was not performed due to the paucity of adherent tissue.The device fragments were subjected to an enzymatic digestion process to remove biologic debris.Following digestion all fragments were examined for material disruptions with the aid of a stereomicroscope and scanning electron microscopy.Disruptions identified were not associated with handling or manufacturing process at w.L.Gore and associates.The disruptions are largely consistent with surgical procedures.Vgf-2 had multiple tears consistent with suture pull through due to tension on the graft; time point cannot be determined.There were no full thickness material disruptions adjacent to the ringed portion of graft suggestive of wall failure, nor was there evidence of graft rupture of the returned graft fragment.
|